Internal Medicine, Hematology & Oncology · Alhambra, CA
NPI
1326023482
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1411 S Garfield Ave Ste 200
Alhambra, CA, 91801
Phone (626) 588-2825
Groups this clinician bills Medicare through
Medicare paid, 2024
$334K
17,838 services
Medicare patients, 2024
223
Average age 74
Drug cost, 2024
$1.6M
374 prescriptions
Company payments, 2025
$140
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yi-Kong Keung was code 99213 (office e&m - established), 280 times for 80 patients. In total Yi-Kong Keung billed 17,838 services in 70 codes, and Medicare paid $334K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 280 | 80 | $71.88 | $20K |
| 85025 Blood Count | Office | 244 | 83 | $7.61 | $1,857 |
| 99231 Hospital E&M - Subsequent | Facility | 185 | 63 | $39.98 | $7,397 |
| 99232 Hospital E&M - Subsequent | Facility | 183 | 77 | $64.28 | $12K |
| 99222 Hospital E&M - Initial | Facility | 76 | 63 | $106.04 | $8,059 |
| 36415 Venipuncture Blood Collection | Office | 69 | 56 | $8.65 | $597 |
| 96372 Injection Administration | Office | 47 | 11 | $12.34 | $580 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 20 | $93.79 | $2,157 |
| 99223 Hospital E&M - Initial | Facility | 19 | 17 | $141.51 | $2,689 |
| 99204 Office E&M - New | Office | 11 | 11 | $142.94 | $1,572 |
By year: 2022 $272K for 10,125 services; 2023 $221K for 9,362 services; 2024 $334K for 17,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 244 | 83 | $7.61 | $1,857 |
| 36415 Venipuncture Blood Collection | 69 | 56 | $8.65 | $597 |
Medicare prescription drug claims, 2024
In 2024, the drug Yi-Kong Keung prescribed most often to Medicare patients was Xgeva (Denosumab), with 33 prescriptions and refills. In total Yi-Kong Keung wrote 374 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xgeva Denosumab | 33 | 33 | Under 11 | $103K |
| Anagrelide Hcl Generic | 24 | 26 | Under 11 | $4,886 |
| Anastrozole Generic | 19 | 45 | Under 11 | $453 |
| Tagrisso Osimertinib Mesylate | 18 | 18 | Under 11 | $340K |
| Eliquis Apixaban | 18 | 26 | Under 11 | $9,498 |
| Exemestane Generic | 12 | 12 | Under 11 | $1,309 |
| Lapatinib Lapatinib Ditosylate | 12 | 12 | Under 11 | $82K |
| Ibrance Palbociclib | 12 | 12 | Under 11 | $183K |
| Dexamethasone Generic | 11 | 12 | Under 11 | $150 |
Brand drugs: - claims; generic drugs: 222 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yi-Kong Keung $140 ($140 in general payments such as food, travel and fees) from 1 company. The largest payer was Agios Pharmaceuticals, Inc. with $140.
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO | 1 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.